July 22, 2017 11:34 PM ET

Biotechnology

Company Overview of Intarcia Therapeutics, Inc.

Key Executives for Intarcia Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Kurt C. Graves 49 RelationshipsExecutive Chairman, Chief Executive Officer and President49
James M. Ahlers No RelationshipsChief Financial Officer and Vice President of Finance & Operations53
Michael Williams No RelationshipsChief Operating Officer--
Michelle Baron M.D., FACENo RelationshipsChief Medical Officer and Vice President of Clinical Research--
Paul L. Feldman Ph.D.No RelationshipsHead of Discovery & Translational Medicine--
View More Key Executives

Intarcia Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Kurt C. Graves 49 RelationshipsIntarcia Therapeutics, Inc.49
Bryan E. Roberts Ph.D. 117 RelationshipsCastlight Health, Inc.50
Glen Y. Sato J.D., M.B.A. 6 RelationshipsCooley LLP58
Irwin Scher M.D. 25 RelationshipsBiosynexus Incorporated67
Gino Santini 64 RelationshipsAMAG Pharmaceuticals, Inc.60
View All Board Members

Intarcia Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
389.7K
Bonus
235.9K
Total Short Term Compensation
483.9K
Total Value of Options
18.3M
Compensation as of Fiscal Year
Intarcia Therapeutics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Neurocrine Biosciences Announces the Appointment of Julie Cooke as Chief People Officer
July 21, 2017 1:28 PM ET
Valens GroWorks Corp. Appoints Saul Katz as President
July 21, 2017 4:19 AM ET
Aeterna Zentaris Inc. Announces Executive Changes
July 20, 2017 9:00 PM ET
Aeglea BioTherapeutics, Inc. Announces Executive Changes
July 20, 2017 8:01 PM ET
Trevena, Inc. Announces the Resignation of David Soergel as Chief Medical Officer
July 20, 2017 7:33 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Intarcia Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.